ITGA2B, F2RL3, PTGS1, and ADCY5 were associated with the platelet activation pathway, while IL18 was linked to inflammatory bowel disease (IBD) and the cytokine–cytokine receptor interaction pathways (Figure 4A). Here, ITGA2B is linked to irritable bowel syndrome.